Intentar ORO - Gratis

BioSpectrum Asia - December 2023

Vuélvete ilimitado con Magzter GOLD

Leer BioSpectrum Asia junto con más de 9000 revistas y periódicos con una sola suscripción

Ver catálogo

1 mes

$14.99

1 año $149.99

$149.99

$12/month

(OR)

Suscríbete sólo a BioSpectrum Asia

Regalo BioSpectrum Asia

Cancelar en cualquier momento.

(Sin compromisos) ⓘ

Si no estás satisfecho con tu suscripción, puedes enviarnos un correo electrónico a help@magzter.com dentro de los 7 días posteriores a la fecha de inicio de la suscripción para recibir un reembolso completo. ¡Sin preguntas, lo prometemos! (Nota: No se aplica a compras de números individuales)

Suscripción digital

Acceso instantáneo ⓘ

Suscríbete ahora para comenzar a leer instantáneamente en el sitio web de Magzter, iOS, Android y las aplicaciones de Amazon.

Verificado seguro

pago ⓘ

Magzter es un comerciante verificado de Authorize.Net. Más información

En este número

Buoyant Life Sciences Sector Emerges Stronger
As we bid farewell to another eventful year in the world of life sciences, it’s time to look back at the whirlwind of advancements and changes that have shaped the industry in 2023. Back in January this year, we interacted with leaders from various market segments who shared their insights into what the year held for their particular spheres. Let’s recap the 2023 predictions and find out if they panned out as predicted.

PROMOTING INDIAN TRADITIONAL MEDICINE

Myanmar and India have been planning joint efforts for the promotion of traditional healthcare systems and medicine in both countries. Recently, in Myanmar, India proposed to set up a Joint Working Group (JWG) to promote cooperation between the two countries in teaching and researching the traditional system of medicine. A bilateral meeting was held in March 2023 in India where possibilities of cooperation in the field of traditional medicines were discussed. Later, in August, a memorandum of understanding (MoU) was signed between the countries in New Delhi on cooperation in the field of traditional medicine when U Kyaw Tin, Myanmar’s Minister of State for Foreign Affairs, was visiting India.

2 mins

Australia releases landmark cancer plan to improve screening, treatment

The Australian Government has released the landmark Australian Cancer Plan, which aims to improve prevention, screening, treatment, and management of all cancers for all people in Australia regardless of their background or where they live.

1 mins

Singapore extends cooperation with China in traditional chinese medicine

Singapore will further its cooperation in several areas of Traditional Chinese Medicine (TCM) with the People’s Republic of China (PRC), with the signing of the 7th Plan of Cooperation (POC) in TCM between Singapore’s Ministry of Health (MoH) and the PRC’s National Administration of TCM (NATCM) recently.

1 mins

India announces women leadership in STEM programme

WOMEN LEADERSHIP IN STEM

1 mins

New Zealand launches national polio response framework

The Ministry of Health in New Zealand has published a new National Poliomyelitis Response Framework, responding to the increased risk of poliovirus globally.

1 mins

East Ventures opens first healthcare fund of $30M in Indonesia

East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, has announced the firm’s first healthcare-focused fund with the amount of $30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.

1 mins

Smith+Nephew introduces REGENETEN Bioinductive Implant in Japan

British medtech company Smith+Nephew has announced the launch of its REGENETEN Bioinductive Implant allowing access to thousands of patients in Japan.

1 mins

Porton Advanced, BioMap jointly develop gene therapies based on AAV vectors

China-based startup Porton Advanced has announced the establishment of a strategic partnership with BioMap.

1 mins

Buoyant Life Sciences Sector Emerges Stronger

As we bid farewell to another eventful year in the world of life sciences, it’s time to look back at the whirlwind of advancements and changes that have shaped the industry in 2023. Back in January this year, we interacted with leaders from various market segments who shared their insights into what the year held for their particular spheres. Let's recap the 2023 predictions and find out if they panned out as predicted.

10+ mins

2 Strategic Trends Driving APAC

In the Asia-Pacific region, we see two key strategic trends within Policy, Access, Value, and Evidence:

3 mins

Asia Toughing Uncertainties Out the and Challenges.

For many looking back at 2023, the word of the year would probably be “uncertainties.” There have been lingering uncertainties about another pandemic, the ongoing wars and atrocities, and the precarious footing of the global economy.

3 mins

How has 2023 panned out for the life sciences industry in Asia Pacific?

Many of the trends in 2023 in life sciences in Asia Pacific were predicted, but there have been some unexpected events, which have caught market participants off-guard. It’s been the year of the expected and the surprises.

4 mins

Pharma Heads Pass Leadership Baton

The pharmaceutical industry is evaluating and adapting to the Great Reset, set in motion back in 2020. One key strategy in this regard has been the change of management structure, with several high-profile leadership changes in 2023. As the euphoria of pandemic-induced record revenues subsided in 2023, the pharmaceutical industry had to reevaluate its strategies and has undergone significant structural changes. Companies adapted their approaches, implementing measures such as job cuts, mergers and acquisitions M&A), and a comprehensive overhaul of top management to navigate the evolving landscape effectively. Big Pharma elites, including Pfizer, Sanofi, Novartis, Astellas, among others, have announced a slew of leadership changes in recent times. Let’s explore these further.

4 mins

"The cancer diagnostics industry is on the cusp of substantial growth, attributed to an aging population"

eadquartered in California, USA, Harae Dx, H a medical diagnostics company is all set to introduce the next generation Artificial Intelligence AI) enabled automated multi-cancer early detection system in India, China and the US in three years-time period. Harae Dx has already secured seed funding from global investor SOSV and is in the process of securing Series A funding of 12 million. The company holds strategic patents in its core technology platform, and the development and manufacturing of the entire diagnostics system will be executed through strategic partnerships using an outsourced model. In an exclusive interview with BioSpectrum Dr Nitin Malekar, Director, Harae Dx Inc., shared his views on the effectiveness of the new technologies being offered and regulatory challenges. Edited excerpts;

4 mins

Focusing on Women's Cancers

Breast and cervical cancer are pressing threats to women and health systems in the Asia Pacific APAC) region. A new multisectoral collaboration and a powerful analysis of six countries’ breast and cervical cancer prevention and care capacity are generating momentum to save lives and contribute to a global health movement.

4 mins

Can Cutting-edge Tech Reduce Rising CVD Burden?

Each year World Heart Day is observed to increase awareness about cardiovascular diseases (CVDs), after all defeating them is something that matters to every beating heart. CVDs are disorders of the heart and blood vessels and are often referred to as “silent killers” because most of the patients with underlying heart ailments do not exhibit any obvious symptoms. Development and deployment of cutting-edge technologies backed by requisite government policy support and direction will help in bolstering the fight against CVDs and thus improving the quality of the individuals’ heart and also their lives. Let’s take a closer look.

8 mins

Biopharma's Evolution and Future Resilience in Asia

As the world emerges from the COVID-19 crisis, the global biopharma industry remains under spotlight. Recent advancements in the sector such as MRNA-based vaccines, use of artificial intelligence Al) in drug discovery, exploration of cell and gene therapies, have the potential to reshape lives, offering hope in the face of looming threats such as pandemics and antimicrobial resistance. Based on five pillars supply chain resilience, talent pool, R&D ecosystem, manufacturing agility, and government policy and regulation, Cytiva has unveiled the findings of the 2023 Global Biopharma Resilience Index, to help us identify the gaps in the industry now, and how to mitigate current challenges for a stronger future within Asia Pacific and Southeast Asia.

4 mins

PolyU, Hefei Luyang establish innovation research institute

The Hong Kong Polytechnic University (PolyU) and the Hefei Luyang government in China have reached an agreement to jointly establish the PolyU-Hefei Technology and Innovation Research Institute, with the aim of fostering in-depth and effective collaboration in industry, academia and research and cultivating talents.

1 mins

Hong Kong designs multimodal robot for post-stroke ankle, foot tele-rehabilitation

The Hong Kong Polytechnic University (PolyU) has achieved another breakthrough in rehabilitation device development.

1 mins

Korea develops metal-enhanced fluorescence probes for influenza A virus detection

In recent years, fluorescence-based lateral flow immunoassay (LFI) has gained popularity as a diagnostic tool for viral detection.

1 mins

Singapore offers innovative magnetic gel to heal diabetic wounds faster

Diabetic patients, whose natural wound-healing capabilities are compromised, often develop chronic wounds that are slow to heal.

1 mins

New research unveils innovative mosquito control strategies in India

Researchers from the Indian Institute of Technology (IIT) Mandi, the Institute for Stem Cell Science and Regenerative Medicine (inStem) in Bengaluru, have discovered the biochemical processes that enable the eggs of the dengue-causing mosquito to survive harsh conditions and rejuvenate when favourable conditions return.

1 mins

Lea todas las historias de BioSpectrum Asia

BioSpectrum Asia Description:

Editor: MM-Activ-Sci-Tech-Communication

Categoría: Business

Idioma: English

Frecuencia: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.